869070-21-3

Basic information

• Product Name: 2-[2-(3-bromo-phenyl)-vinyl]-benzoic acid
• Synonyms: 2-[2-(3-bromo-phenyl)-vinyl]-benzoic acid
• CAS NO: 869070-21-3
• Molecular Weight: 303.155
• Mol File: 869070-21-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2-[2-(3-bromo-phenyl)-vinyl]-benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[2-(3-bromo-phenyl)-vinyl]-benzoic acid(869070-21-3)
• EPA Substance Registry System: 2-[2-(3-bromo-phenyl)-vinyl]-benzoic acid(869070-21-3)

Safety Data

• Hazardous Substances Data: 869070-21-3(Hazardous Substances Data)

Upstream product

• 2417-73-4 methyl 2-bromomethylbenzoate 
• 89-71-4 2-Methyl-benzoic acid methyl ester 
• 591-17-3 meta-bromotoluene 
• 128833-03-4 P-[(3-bromophenyl)methyl]phosphonic acid diethyl ester 
• 119-67-5 o-carboxybenzaldehyde 

Downstream Products

• 869070-31-5 2-phenyl-10,11-dihydro-dibenzo[a,d]cyclohepten-5-one 
• 869070-29-1 {4-[2-(2-bromo-10,11-dihydro-dibenzo[a,d]cyclohepten-5-ylidene)-ethylsulfanyl]-2-methyl-phenoxy}-acetic acid ethyl ester 
• 198707-82-3 2-bromo-10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-one 
• 198707-81-2 2-(3-bromophenethyl)benzoic acid 
• 4890-85-1 o-phenethylbenzoic acid 

Relevant articles and documents

Polycyclic pyridone derivative, pharmaceutical composition and application thereof

The invention belongs to the field of medicines, and relates to a polycyclic pyridone derivative, a pharmaceutical composition and application thereof. The polycyclic pyridone derivative is a compound as shown in a formula (I) or a stereoisomer, a tautomer, a nitric oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or prodrugs of the compound as shown in the formula (I). Compared with the existing similar compounds, the compound disclosed by the invention not only can well inhibit the replication of influenza viruses, but also has lower cytotoxicity.

NOVEL COMPOUNDS, THEIR PREPARATION AND USE

Novel compounds of the general formula (I), the use of these compounds as phar- maceutical compositions, pharmaceutical compositions comprising the compounds and methods of treatment employing these compounds and compositions. The present compounds may be useful in the treatment and/or prevention of conditions mediated by Peroxisome Proliferator-Activated Receptors (PPAR), in particular the PPARδ suptype.